Skip to main content

Table 4 Multivariate analysis of types of kidney disease and associated variables in type 2 diabetic patients

From: Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area

 

Renal impairment OR (CI 95%)

Nonalbuminuric RI OR (CI 95%)

Diabetic nephropathy OR (CI 95%)

Gender (men) women

2.20 (1.86–2.54)

0.27 (0.21–0.35)

0.56 (0.400.78)

Diabetes duration (≤10) & 10 years

1.43 (1.18–1.74)

0.66 (0.48–1.08)

0.80 (0.54–1.19)

D Diabetes duration For year

1.03 (1.02–1.05)

0.94 (0.91–0.97)

0.97 (0.94–1.1)

ACEI/ARB treatment (No) Yes

1.51 (1.27–1.79)

1.42 (1.09–1.84)

0.98 (0.70–1.37)

BP (≤ 130/80 mmHg) & 130/80 mmHg

0.86 (0.69–1.06)

2.16 (0.90–3.57)

1.18 (0.60–2.32)

HbA1c for each 1% of increase

0.85 (0.80-0.91)

1.19 (1.09-1.30)

1.21 (0.96-1.37)

Insulin treatment (No) Yes

1.82 (1.39-2.38)

1.42 (1.08-1.84)

4.17 (2.33-7.44)

Microvascular disease (No) Yes

2.14 (1.80-2.54)

-

-

  1. In bold: p < 0.01;
  2. Adjusted also for age, body mass index, total cholesterol and non-HDL cholesterol, pulse pressure and macrovascular disease.
  3. RI: renal impairment. Glomerular filtration rate < 60 mil/min/1.73 m2. Diabetic nephropathy: albuminuria & 300 mg/gr or albuminuria 30–300 mg/gr plus retinopathy. Albuminuria: albuminuria & 30 mg/gr.; ACEI: angiotensin-converting enyme inhibitor; ARB: angiotensin receptor blocker; BP: blood pressure; HbA1c; glycated haemoglobin; Microvascular disease: albuminuria and/or diabetic retinopathy.